Researchers have developed a more accurate way to predict the risk of developing cardiovascular disease among women, according to a study in the February 14 issue of JAMA.
A CNRS team headed by Philippe Froguel (CNRS, University of Lille 2, Pasteur Institute, Imperial College London) and Rob Sladek (McGill University, Montreal, Canada) in a French-British-Canadian collaboration that accounts for about 70 percent of the genetic risk for patients with type two diabetes.
Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.
People from lower socioeconomic backgrounds who suffer a heart attack come to the emergency department more often, are less likely to be treated aggressively and have higher mortality rates a year after the attack, says new University of Alberta research that has important implications for access to cardiac care.
A large animal study has shown that certain microsecond electrical pulses can punch nanoscale holes in the membranes of target cells without harming tissue scaffolding, including that in the blood vessels – a potential breakthrough in minimally invasive surgical treatments of tumors.
The long-term safety of the CYPHER(R) Sirolimus-eluting Coronary Stent, specifically in terms of death, myocardial infarction (heart attacks) and stent thrombosis (also known as blood clots), is comparable to that of bare metal stents when used according to product labeling, according to a variety of studies appearing today in the New England Journal of Medicine (NEJM).
An unsubstantiated but well-publicised claim by The Gambia’s President Yahya Jammeh that he can cure AIDS risks setting back efforts to stop the virus from spreading in the tiny West Africa nation and the region, campaigners warn.
Testing for tuberculosis has revealed that nearly 40 percent of the doctors in one Russian city have latent infection, with even higher levels in those who work in TB clinics. The research has been published in PLoS Medicine.
The Food and Drug Administration (FDA) today announced revisions to the labeling for the antibiotic Ketek (telithromycin) designed to improve the safe use of Ketek by patients.
New research published in the February issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), suggests that high-risk smokers with acute cardiovascular disease are three to four times more likely to quit smoking when treated with an intensive smoking cessation program.